Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
AstraZeneca Withdraws Imfinzi U.S. Indicator for Advanced Bladder Cancer
[Image: 7a483afcdbe480eb3105d539371d8d49]

AstraZeneca will voluntarily withdraw the use of the เกมสล็อตฟรี cancer drug Imfinzi to treat advanced bladder cancer in the United States after failing to meet post-approval requirements, the Anglo-Swedish drugmaker said on Monday.Imfinzi, mainly a lung cancer drug, received expedited approval for the bladder cancer indication in 2017, and its withdrawal had no impact on markets outside the United States, the company said.The treatment failed to meet the main goal of the trial late last year, and the decision was up in consultation with the U.S. agency, the company said.While withdrawal in previously treated metastatic bladder cancer is disappointing, it is disappointing.
But we respect the principles the FDA had in place when the accelerated approval path was established, ”Dave Fredrickson, the company's executive vice president of oncology business, said in a statement.Imfinzi belongs to the class of immunotherapy that increases the body's defenses against cancer by using antibodies that block or bind to foreign bodies in the body.AstraZeneca also said other U.S. indications for the drug, which grossed $ 2.04 billion last year, were not impacted by the withdrawal, along with informing healthcare providers. Know the improvements

Forum Jump:

Users browsing this thread: 1 Guest(s)